Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,905 | -10,727 | -7,727 | -3,861 | -15,508 |
| Depreciation Amortization | 649 | 487 | 325 | 162 | 649 |
| Other Working Capital | -1,519 | -1,975 | -1,474 | -942 | 1,574 |
| Other Operating Activity | 852 | 735 | 516 | 320 | 471 |
| Operating Cash Flow | $-13,923 | $-11,480 | $-8,360 | $-4,321 | $-12,814 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 75 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $75 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 392 |
| Debt Repayment | N/A | -458 | N/A | N/A | -392 |
| Common Stock Issued | 0 | 4,999 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -3,726 |
| Other Financing Activity | 4,517 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $4,518 | $4,541 | $0 | $N/A | $-3,726 |
| Exchange Rate Effect | -3 | -31 | -4 | -1 | -4 |
| Beginning Cash Position | 16,331 | 16,331 | 16,331 | 16,331 | 33,088 |
| End Cash Position | 6,923 | 9,361 | 7,968 | 12,009 | 16,331 |
| Net Cash Flow | $-9,408 | $-6,970 | $-8,364 | $-4,322 | $-16,757 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,923 | -11,480 | -8,360 | -4,321 | -12,814 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -34 |
| Free Cash Flow | -13,923 | -11,480 | -8,360 | -4,321 | -12,848 |